/PRNewswire/ Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reports.
Leveraging the established EZ-fill market-leading technology, process, and product optimization to improve quality, reduce total cost of ownership, and shorten lead times Stevanato Group S.p.A.
Gerresheimer AG (OTCPK:GRRMF) Q3 2022 Earnings Conference Call October 12, 2022 4:00 AM ET Company Participants Carolin Nadilo - Head of Investor Relations Dietmar Siemssen - Chief.
EQS-News: Gerresheimer AG / Key word(s): Quarterly / Interim Statement/Quarter ResultsGerresheimer AG: Gerresheimer reports double digit growth in revenue and earnings for the third quarter 12.10.2022 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Gerresheimer reports double di.
DGAP-News: Gerresheimer AG / Key word(s): AllianceGerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry 07.09.2022 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.